FDA Refused 22 Shrimp Entry Lines In April-May For Banned Antibiotics

The U.S. Food and Drug Administration (FDA) has released information regarding entry line refusals for the period running from Tuesday, April 18th through Friday, May 26th.  For the full month of April and all but three days of May, 22 of the 227 (9.7%) total seafood entry line refusals reported have been of shrimp for reasons related to banned antibiotics.

The twenty-two shrimp entry lines refused by the FDA for banned antibiotics in April and May were from China, Hong Kong, India, and Vietnam and were reported by four different FDA import divisions:

• Suryamitra Exim Pvt Ltd (India), a company that is not currently listed on Import Alert 16-124, Import Alert 16-127, or Import Alert 16-129 (Suryamitra had been listed on Import Alert 16-129 for nitrofurans since March 15, 2017 but was removed from the list on June 2, 2017), had one entry line refused for shrimp contaminated with nitrofurans and veterinary drug residues by the Division of Northeast Imports on April 1, 2017;
• Bluepark Seafoods (India), a company that was added to Import Alert 16-129 for nitrofurans in its shrimp on May 15, 2017, had one entry line refused for shrimp contaminated with veterinary drug residues by the Division of Northeast Imports on April 5, 2017;

To read the rest of the story, please go to: Southern Shrimp Alliance